Combined-Modality Therapy for Esophageal Cancer
- 1 July 2003
- journal article
- editorial
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 9 (4) , 238-240
- https://doi.org/10.1097/00130404-200307000-00003
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival*Diseases of the Esophagus, 2002
- A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: Initial resultsThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002
- A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junctionCancer, 2001
- Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal CarcinomaJournal of Clinical Oncology, 2001
- Does Paclitaxel Improve the Chemoradiotherapy of Locoregionally Advanced Esophageal Cancer? A Nonrandomized Comparison With Fluorouracil-Based TherapyJournal of Clinical Oncology, 2000
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal CancerNew England Journal of Medicine, 1998
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the EsophagusNew England Journal of Medicine, 1997
- A Comparison of Multimodal Therapy and Surgery for Esophageal AdenocarcinomaNew England Journal of Medicine, 1996
- A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagusCancer, 1994